ARCHIVES

HRSA: Discounts Owed on Some Orphan Drug Uses

This article is from The Cancer Letter archive.

Vol. 40 No. 40 | October 24, 2014

Download PDF Visit The Full Archive

Related Articles

NCI Plans Preclinical Studies Of Endoxifen, A Tamoxifen Metabolite.

August 7, 2009

NIH Panel Outlines Strategies To Manage Adrenal Tumors.

February 22, 2002

NCI Considering DRCCA Request to Fund More CCOPs for Better Distribution; Some Will Be Rereviewed

August 19, 1983

Celebrex Studied As Potential Prevention Of Lung Cancer In High-Risk Populations

August 31, 2001

Lower Stomach Cancers Increasing In Younger U.S. Whites, Study Finds

May 28, 2010

In Brief: Charles Heidelberger, Sol Spiegelman Both Die of Cancer; Robert Wittes New CTEP Director

January 28, 1983